Cargando…
Novel Therapeutic Mechanism of Adipose-Derived Mesenchymal Stem Cells in Osteoarthritis via Upregulation of BTG2
BACKGROUND: Osteoarthritis (OA) is a debilitating and degenerative joint disease, which is characterized by progressive destruction of articular cartilage. Mesenchymal stem cells (MSCs) have been implicated in the treatment of OA. However, the function of adipose-derived MSCs (AD-MSCs) in OA and its...
Autores principales: | Yang, Qinyan, Jin, Li, Ding, Qian, Hu, Wei, Zou, HaiBo, Xiao, Mingming, Chen, Keyuan, Yu, Yue, Shang, Jin, Huang, Xiaolun, Zhu, Yizhun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590117/ https://www.ncbi.nlm.nih.gov/pubmed/36299602 http://dx.doi.org/10.1155/2022/9252319 |
Ejemplares similares
-
Retracted: Novel Therapeutic Mechanism of Adipose-Derived Mesenchymal Stem Cells in Osteoarthritis via Upregulation of BTG2
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023) -
Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and remodeling choline metabolism
por: Zhang, Zilong, et al.
Publicado: (2023) -
Emerging role of antiproliferative protein BTG1 and BTG2
por: Kim, Sang Hyeon, et al.
Publicado: (2022) -
Identification of polyunsaturated fatty acids as potential biomarkers of osteoarthritis after sodium hyaluronate and mesenchymal stem cell treatment through metabolomics
por: Yang, Qinyan, et al.
Publicado: (2023) -
Tumor suppressors BTG1 and BTG2: Beyond growth control
por: Yuniati, Laurensia, et al.
Publicado: (2018)